Juki W Ng (Juki Ng)

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 4

Top Topics

Drug Administration

Top Venues

Clinical pharmacokinetics

CPT: pharmacometrics & systems pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Manoj S Chiney, Juki W Ng, John P Gibbs, Mohamad Shebley
Quantitative Assessment of Elagolix Enzyme-Transporter Interplay and Drug-Drug Interactions Using Physiologically Based Pharmacokinetic Modeling. Clinical pharmacokinetics 59 (5) (2021)
Mohamad Shebley, Akshanth R Polepally, Ahmed Nader, Juki W Ng, Insa Winzenborg, Cheri E Klein, Peter Noertersheuser, Megan A Gibbs, Nael M Mostafa
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis. Clinical pharmacokinetics 59 (3) (2021)
Robert A Feldman, Yi-Lin Chiu, Cheri E Klein, Juki W Ng
Pharmacokinetic and Pharmacodynamic Profiles of Ethinylestradiol/Norgestimate Combination or Norethindrone upon Coadministration with Elagolix 150 mg Once Daily in Healthy Premenopausal Women. Clinical pharmacokinetics 60 (8) (2021)
Insa Winzenborg, Akshanth R Polepally, Ahmed Nader, Nael M Mostafa, Peter Noertersheuser, Juki W Ng
Effect of Elagolix Exposure on Clinical Efficacy End Points in Phase III Trials in Women With Endometriosis-Associated Pain: An Application of Markov Model. CPT: pharmacometrics & systems pharmacology 9 (8) (2020)